Bausch Health Companies | VRX - Interest Expense On Debt

Stock Price
8.31
Daily Change
0.10 1.16%
Monthly
4.33%
Yearly
-23.03%
Q1 Forecast
8.16

Bausch Health Companies reported $412M in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
Amgen USD 653M 32M Dec/2025
ANI Pharmaceuticals USD 4.73M 711K Sep/2025
Aurora Cannabis CAD 2.22M 442K Sep/2025
Bausch Health Companies USD 412M 53M Sep/2025
Biogen USD 72.6M 12.6M Jun/2025
Bristol-Myers Squibb USD 432M 48M Dec/2025
Canopy Growth CAD 8.8M 938K Sep/2025
Corcept Therapeutics USD 823.61M 21.88M Sep/2025
Danaher USD 55M 12M Dec/2025
Drreddys Laboratories INR 944M 127M Dec/2025
Eli Lilly USD 114.7M 134.3M Sep/2025
Gilead Sciences USD 255M 1000K Dec/2025
Nektar Therapeutics USD 6.02M 420K Sep/2024
Novo Nordisk DKK 1.53B 3.43B Sep/2025
Pacira USD 4.28M 456K Sep/2025
Perrigo USD 10.08B 10.04B Sep/2025
Phibro Animal Health USD 8.76M 2.76M Sep/2024
Prestige Brands USD 10.67M 636K Dec/2025
Supernus Pharmaceuticals USD 910K 278K Jun/2023
Vertex Pharmaceuticals USD 3.3M 0 Dec/2025
Zoetis USD 57M 1000K Dec/2025